OncoSec to Present TAVO(TM) Immune Biomarker Data Associated with Positive Clinical Response from Ongoing KEYNOTE Studies at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.